{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-040034","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.184763+00:00","generated_at":"2026-06-05T23:15:39.819731+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vir Biotechnology CMO Phil Pang to leave at end of March 2024; successor search started","bullets":["Executive VP and Chief Medical Officer Phil Pang, M.D., Ph.D. departing at end of March 2024, citing family reasons.","Company has initiated a search for a new Chief Medical Officer.","No interim CMO named; transition expected by end of March 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-040034","json":"https://secwatch.observer/filing/0001193125-24-040034.json","markdown":"https://secwatch.observer/filing/0001193125-24-040034.md","text":"https://secwatch.observer/filing/0001193125-24-040034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000119312524040034/0001193125-24-040034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000119312524040034/d793408d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:15:39.819731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4869c601d3","claim":"Phil Pang departed as Executive Vice President and Chief Medical Officer at Vir Biotechnology, Inc..","evidence_excerpt":"On February 20, 2024, Vir Biotechnology, Inc. (the “Company”) announced that Executive Vice President and Chief Medical Officer, Phil Pang, M.D., Ph.D. has decided to leave the Company at the end of March 2024 to spend more time with his family.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1706431/000119312524040034/0001193125-24-040034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"decided to leave"},{"label":"Role","value":"Executive Vice President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}